T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Broadcom
AVGO
|
+$2.74B |
| 3 |
Microsoft
MSFT
|
+$2.33B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.47B |
| 5 |
GE Aerospace
GE
|
+$1.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.42B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.44B |
| 3 |
Apple
AAPL
|
+$2.42B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.3B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.73% |
| 2 | Financials | 12.11% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Nurix Therapeutics
NRIX
$2.82B
| $34.6M | ﹤0.01% |
3,033,844
+120,476
| +4% | +$1.3M |
|
827
Pebblebrook Hotel Trust
PEB
$2.05B
| $34.4M | ﹤0.01% |
3,442,747
+277,261
| +9% | +$2.58M |
|
828
Church & Dwight Co
CHD
$24B
| $34.2M | ﹤0.01% |
356,243
+2,283
| +0.6% | +$225K |
|
829
Cincinnati Financial
CINF
$26.5B
| $33.9M | ﹤0.01% |
227,911
-1,032
| -0.5% | -$148K |
|
830
Builders FirstSource
BLDR
$7.91B
| $33.9M | ﹤0.01% |
290,128
-1,119
| -0.4% | -$129K |
|
831
Wave Life Sciences
WVE
$1.02B
| $33.7M | ﹤0.01% |
5,190,403
+1,065,112
| +26% | +$7.03M |
|
832
Blue Owl Capital
OWL
$19.7B
| $33.7M | ﹤0.01% |
1,755,172
+389,768
| +29% | +$7.21M |
|
833
Eversource Energy
ES
$27.2B
| $33.7M | ﹤0.01% |
529,278
+5,346
| +1% | +$329K |
|
834
Wynn Resorts
WYNN
$10.5B
| $33.6M | ﹤0.01% |
358,785
-440,462
| -55% | -$37.4M |
|
835
Casella Waste Systems
CWST
$5.79B
| $33.4M | ﹤0.01% |
289,746
+3,997
| +1% | +$462K |
|
836
HP
HPQ
$28.6B
| $33.4M | ﹤0.01% |
1,364,686
-12,419
| -0.9% | -$316K |
|
837
Dorman Products
DORM
$3.95B
| $33.1M | ﹤0.01% |
269,747
+248,647
| +1,178% | +$30.2M |
|
838
Apogee Therapeutics
APGE
$10.2B
| $33M | ﹤0.01% |
760,844
-61,006
| -7% | -$2.32M |
|
839
United Therapeutics
UTHR
$21.5B
| $32.9M | ﹤0.01% |
114,502
-75,229
| -40% | -$22.5M |
|
840
Zegna
ZGN
$3.73B
| $32.7M | ﹤0.01% |
3,819,952
+67,088
| +2% | +$541K |
|
841
NiSource
NI
$20.2B
| $32.6M | ﹤0.01% |
807,397
-657,202
| -45% | -$25.8M |
|
842
Wheaton Precious Metals
WPM
$59.9B
| $32.5M | ﹤0.01% |
362,130
-45,012
| -11% | -$3.79M |
|
843
Medpace
MEDP
$16.2B
| $32.4M | ﹤0.01% |
103,304
-4,071
| -4% | -$1.22M |
|
844
FTAI Aviation
FTAI
$22.2B
| $32.3M | ﹤0.01% |
281,145
-127,222
| -31% | -$14.2M |
|
|
BLD
845
DELISTED
TopBuild
BLD
| $32.3M | ﹤0.01% |
99,632
+5,826
| +6% | +$1.73M |
|
846
W.R. Berkley
WRB
$26.2B
| $32.1M | ﹤0.01% |
436,730
-3,395
| -0.8% | -$243K |
|
847
Rollins
ROL
$17.4B
| $32M | ﹤0.01% |
567,961
-25,853
| -4% | -$1.45M |
|
848
Visteon
VC
$2.86B
| $32M | ﹤0.01% |
342,908
+3,244
| +1% | +$267K |
|
849
Ryan Specialty Holdings
RYAN
$11B
| $31.8M | ﹤0.01% |
467,963
-52,131
| -10% | -$3.6M |
|
850
Labcorp
LH
$26.2B
| $31.6M | ﹤0.01% |
120,508
-83,422
| -41% | -$20.3M |
|
Similar funds
T. Rowe Price Associates's Q2 2025 Portfolio in Review
As of Q2 2025, T. Rowe Price Associates held 3,193 positions worth $883B, up 8.8% from $812B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2025 filing shows 153 new, 2,010 increased, 803 reduced and 136 closed positions. Its largest new stake was Ralliant Corp: 4,667,638 shares worth $226M. The largest sale was Amazon, an estimated $3.42B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q2 2025 buy was Ralliant Corp: 4,667,638 shares worth $226M.
- T. Rowe Price Associates added most to NVIDIA in Q2 2025, an estimated $3.94B increase.
- T. Rowe Price Associates's biggest Q2 2025 reduction was Amazon, cutting an estimated $3.42B.
- T. Rowe Price Associates fully exited US Steel in Q2 2025, selling an estimated $146M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $883B portfolio in Q2 2025.
- T. Rowe Price Associates opened 153 new positions and closed 136 in Q2 2025.
- T. Rowe Price Associates's portfolio value rose 8.8% quarter-over-quarter to $883B.
Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.